The Hormone Wars: Small Business and Patients Duke it Out Against Big Pharma and Win

The Court's ruling for patient access to compoundedaffected -- menopausal women and andropausal men;
medicines ensures that patients and physicians willthe Autistic community; men and women with HIV or
continue to have access to vital medicines includingAIDS; young children with gastroesophageal reflux
bio-identical hormones.This was a big victory fordisease (GERD); hospice and nursing home patients;
patients who rely on customized medicines, especiallypeople who are very sensitive to dyes and additives in
for women taking bio-identical hormone therapy.medicines, as well as head trauma victims whose lives
Advocates including small pharmacies and makers ofcan be saved by compounded bio-identicals.
alternative therapies including T.S. Wiley.It all started when last October of 2006, out of the
A ruling by U.S. District Court Judge Robert Junell inblue, Wyeth (WYE), filed a complaint with the federal
August indicate that patients and physicians have wonFDA to take action against the small pharmacies
the battle against Big Pharma, and therefore willmaking bioidentical hormones from soy and other plant
continue to have access to vital compoundedmaterials. Initially there was concern of the dangers of
medicines. This victory for patients who rely onprescription hormones for women thanks to a major
customized medicines, is especially sweet for womenstudy by the National Institutes of Health (NIH) known
taking bio-identical hormone therapy. Small pharmaciesas the Women's Health Initiative (WHI). It suggested
and makers of alternative therapies includingthat taking hormones made by Wyeth could lead to
developers like T.S. Wiley (the Wiley Protocol)increased risk of heart problems and breast cancer.
bio-identical hormone replacement therapy, doctors,Recently a new study was published in the Journal of
patients, and other industry organizations includingthe American Medical Association, mentioning that the
compounding pharmacists stood up to this legislationrisks were overstated. As synthetic hormones known
and fought hard to win.as Premarin and PremPro were deemed dangerous,
"It is in the best interest of public health," ruled Junell, tothe assumption among women using bio-identical
uphold the legality of compounded drugs. He also saidregimens is that they are actually doing something
that this legislation passed by Congress exempts"safer."
compounding pharmacies from such detailed FederalAs some experts pointed out, the WHI never looked
Drug Administration (FDA) inspections. "It is not feasible,at hormones, but only drugs with "hormone-like"
either economically or time-wise, for the neededeffects that were dosed in a regimen far from that of
medications to be subjected to the FDA approvalhuman replacement.
process."The fact that the Court ruled in favor of patient
This is good news for women on new alternativeaccess to compounded medicines ensures that
therapies such as compounded bio-identicals becausepatients and physicians will continue to have access to
this battle over hormones for women affects a hugevital compounded medicines. This will also will allow
market. And there are over 40 million women in themore research and clinical trials to take place on
U.S. from the age of 40 to 60. Around 25 millionbio-identical hormones. This could prove that Wiley's
women annually go into menopause. It is estimatedrevolutionary discovery is accurate - the fact that it's
that by the year 2030, that number will increase to 47the rhythm that matters in the accurate physiological
million women per year.replacement of hormones without side-effects for
Advocates like Wiley, a medical theorist in the field ofwomen in the second half of life.
environmental endocrinology and a writer andWiley's findings may have important implications across
researcher on the use of hormones, testified on Aprila wide range of areas, from the treatment of
19, 2007 before the Special Committee on Aging atmenopause and anti-aging to all of the other diseases
the United States Senate. Wiley's in depth testimony isof aging such as heart disease and stroke, Type II
available in the Library of Congress.diabetes, cancer and Alzheimer's disease.
This testimony sites those who would have been